Skip to main content
OTLK logo
OTLK
(NASDAQ)
Outlook Therapeutics, Inc.
$1.32-- (--)
Loading... - Market loading

Outlook Therapeutics (OTLK) Stock Price & Financial Analysis

Outlook Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.26 - $1.35
52-Week High$3.39
52-Week Low$0.16
Open$1.32
Volume5.97M
Average Volume (3M)14.04M
Market Cap33.63M
Shares Outstanding25.48M
Price to Sales (P/S)100.94
Price to Book (P/B)-1.16
EV/EBITDA-0.85
Revenue (TTM)333.14K
Net Income (TTM)-60.96M
Free Cash Flow (TTM)-47.05M
EPS (TTM)$-1.44
Profit Margin-18297.50%
Operating Margin-18182.76%
50-Day MA$1.10
200-Day MA$0.94
52-Week Change-36.54%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Outlook Therapeutics

What is the current stock price for OTLK?

As of the latest trading session, OTLK stock trades at $1.32. The 52-week range is $0.16–$3.39, with a day range of $1.26–$1.34.

What is the P/E ratio for OTLK?

The P/E ratio (Price-to-Earnings) for OTLK is shown in the Key Statistics section. This valuation metric helps compare Outlook Therapeutics, Inc. to industry peers.

Does OTLK pay dividends?

Outlook Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OTLK?

Analyst ratings and recommendations for OTLK are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of OTLK?

Outlook Therapeutics's market capitalization is $33.6M, classifying it as a micro-cap company. Outlook Therapeutics operates in the Healthcare sector within the Biotechnology industry.